Market Insights Snapshot
In California, Papa & Barkley has shown consistent performance in several categories. The brand has maintained its top position in the Tincture & Sublingual and Topical categories consistently from August to November 2023. However, in the Capsules category, the brand's rank has hovered around the 7th and 8th positions, indicating a strong but not leading presence. The brand's performance in the Edible category has been slightly less impressive, with rankings just outside the top 20. Interestingly, the brand made a notable entry in the Concentrates category in November, debuting at the 96th rank, indicating a potential area of growth.
Moving over to Michigan, Papa & Barkley's presence is less pronounced. The brand ranked 9th in the Capsules category in August, but no data is available for the following months, suggesting that it may have dropped out of the top 20. In the Tincture & Sublingual category, the brand started at the 27th rank in August and improved to 24th in September. The Topical category showed a rank of 30 in August, but again, data for the following months is missing. This suggests that while Papa & Barkley has a presence in Michigan, it's not as dominant as in California.
In the California Topical category, Papa & Barkley continues to maintain its leading position, consistently ranking first from August to November 2023. However, it's worth noting that their sales have seen a slight downward trend during this period. Their closest competitor, Mary's Medicinals, holds the second rank consistently, but their sales have been relatively stable, showing a minor increase over the same period. The third-ranking brand, Buddies, also exhibits a downward sales trend, but their sales volume is significantly lower than both Papa & Barkley and Mary's Medicinals. This data suggests that while Papa & Barkley remains the dominant brand, there is potential for competition, particularly from Mary's Medicinals, if the downward sales trend for Papa & Barkley continues.
In November 2023, Papa & Barkley's top-selling product was the CBD/THC 1:3 THC Rich Releaf Balm (100mg CBD, 300mg THC, 50ml) from the Topical category, maintaining its number one rank from previous months with sales reaching 6875 units. The second best-seller was the CBD/THC/CBN 2:4:1 Sleep Releaf Blackberry Elderberry Gummies 20-Pack (40mg CBD, 80mg THC, 20mg CBN) in the Edible category, selling 5894 units. The third spot was taken by another Topical product, the CBD/THC 1:3 THC Rich Releaf Balm (30mg CBD, 90mg THC, 15ml) with 4818 units sold. The fourth and fifth spots were held by the CBD/THC 3:1 CBD Rich Releaf Balm (135mg CBD, 33mg THC, 15ml) and CBD/THC 3:1 CBD Rich Releaf Balm (450mg CBD, 150mg THC, 50ml), both from the Topical category, with 4690 and 3789 units sold respectively. The rankings remained consistent from the previous month, indicating a stable demand for these products.